The pharmaceutical company has invested in healthcare analytics software provider Caresyntax through its corporate venturing subsidiary.
Norgine Ventures, corporate venture capital arm of pharmaceutical company Norgine, has invested $11.9m in US-based medical analytics software producer Caresyntax.
Caresyntax provides hospitals and medical centres with an analytics platform that takes data from surgical devices and patients’ electronic health records to provide insights that help senior management manage risk, reduce surgical variability and automate workflows.
The funding will be used to speed up product development, open a new US office in Boston and add more than 10 new employees…
